Reduction of acute myocardial infarction mortality in Chilean hospitals;Reducción de la mortalidad por infarto del miocardio en hospitales chilenos

Revista Medica de Chile

Volumn 130, Issue 4, 2002, Pages 368-378

  Corbalán H, Ramón ^a,b   Nazzal N, Carolina ^a   Prieto D, Juan Carlos ^a   Chávez S, Eduardo ^a   Lanas Z, Fernando ^a   Lamich B, Rubén ^a   Bartolucci J, Jorge ^a   Montaño E, Rosa ^a   Cumsille G, Francisco ^a  

^a GEMI ^*  (France)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Adrenergic beta antagonists; Calcium channel blockers; Hospital mortality; Myocardial infarction; Nitrates

Indexed keywords

AGED; ARTICLE; CHILE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; FEMALE; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; RISK FACTOR;

AGED; CHILE; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 0036526798     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. RYAN T, ANTMANN E, BROOKS N, CALIFF R, HILLIS D, HIRATZKA L, RAPAPORT E ET AL. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations. Circulation 1999; 100: 1016-30.
2. GUARDA E, YORANOVIC J, CHAMORRO H, PRIETO JC, CORBALÁN R. Pautas para el manejo intrahospitalario del infarto agudo del miocardio. Rev Chil Cardiol 2001; 20:1: 52-66.
3. Guidelines. Acute myocardial infarction: prehospital in-hospital management. Task Force of the European Society of Cardiology. Eur Heart J 1996; 17: 43-63.
4. ROGERS W, CANTO J, LAMBREW C, TIEFENBRUNN A, KINKAID B ET AL FOR THE INVESTIGATORS IN THE NATIONAL REGISTRY OF MYOCARDIAL INFARCTION 1, 2 AND 3. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 trough 1999. J Am Coll Cardiol 2000: 36; 7: 2056-63.
5. GIL M, MARRUGAT J, SALA J, MASIA R, ELOUSA X, PENA A, VILA J ET AL. Relationship of therapeutic improvement and 28 days case fatality in patients hospitalized with acute myocardial infarction between 1978 and 1993 in the Regicor study. Gerona, Spain. The Regicor investigators. Circulation 1999; 99; 1767-73.
6. GOLDBERG RJ, YARZEBSKI J, LESSARD D, GORE JM. A two decades (1975 to 1995) long experience in the incidence, in hospital and long term case fatality rates of acute myocardial infarction: a community wide perspective. J Am Coll Cardiol 1999; 33: 1533-9.
7. MCGOVERN PG, PANKOW JS, SHAHAR E, DOLISZNY KM, FOLSOM AR, BLACKBURN H, LUEPKER RV. Recent trends in acute coronary heart disease mortality, morbidity, medical care and risk factors. The Minnesota Heart Survey Investigators. N Engl J Med 1996; 334: 884-90.
8. DAUERMAN H, LESSARD D, YARZEBSKI J, FURMAN MI, GORE JM, GOLBERG RJ. Ten years trends in the incidence, treatment and outcome of Q wave myocardial infarction. Am J Cardiol 2000; 86: 730-5.
9. GRUPO GEMI: ¿Es posible para la cardiología chilena realizar estudios multicéntricos? Grupo de estudio multicéntrico del infarto (GEMI). Farmacoepidemiología del infarto agudo del miocardio en centros hospitalarios chilenos. Rev Chil Cardiol 1993; 12: 153-60.
10. Farmacoepidemiología del infarto agudo del miocardio en 33 hospitales chilenos. Grupo de estudio multicéntrico del infarto (GEMI). Rev Chil Cardiol 1995; 14: 11-9.
11. PRIETO JC, CORBALÁN R, CHÁVEZ E, LANAS F, CUMSILLE F, NAZZAL C. Infarto agudo del miocardio en hospitales chilenos. Resultados finales del estudio GEMI. Rev Méd Chile 1999; 127: 763-74.
12. CORBALÁN R. Reducción de mortalidad en los pacientes con infarto del miocardio en Chile. Rev Chil Cardiol 2000; 19: 3: 141 (Abstract).
13. O'CONNOR G, MALENKA D, QUINTON H, ROBB J, KELLET M, SHUBROOKS S, DRADLEY W ET AL. Multivariate prediction of in-hospital mortality after percutaneous coronary interventions in 1994-1996. J Am Coll Cardiol 1999; 34: 681-91.
14. MORROW D, ANTMAN E, CHARLESWORTH A, CAIRNS R, MURPHY S, DE LEMOS J, GIUGLIANO R ET AL. TIMI risk score for ST-Elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation. An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000; 100: 2031-7.
15. VOLPI A, DE VITA C, FRANZONI MG, GERACI E, MAGGIONI A, MAURI F, NEGRI E ET AL. Determinants of 6 months mortality in survivors of myocardial infarction after thrombolysis: Results of the GISSI-2 data base. Circulation 1993; 88: 416-29.
16. DUBOIS C, PIERARD LA, ALBERT A, SMEETS JP, DEMOULIN JC, BOLAND J, KULBERTUS HE. Short-term risk stratification at admision based on simple clinical data in acute myocardial infarction. Am J Cardiol 1988; 61: 216-9.
17. LEE KL, WOODLIEF LH, TOPOL EJ, WEAVER D, BETRIU A, COL J, SIMOONS M ET AL. Predictors of 30 days mortality in the era of reperfusion for acute myocardial infarction: Results from an international trial of 41.029 patients. Circulation 1995; 91: 1659-60.
18. PRIETO JC, CORBALÁN R, NAZZAL C, CHÁVEZ E, LANAS F, BARTOLUCCI J, CUMSILLE F. Cambios en los patrones de prescripción de medicamentos en el infarto agudo del miocardio. Comparación de dos períodos. Rev Méd Chile 2001; 129: 481-8.
19. HJALMARSON A, ELMFELDT D, HERLITZ J, HOLMBERG S, MÁLEK I, NYBERG G, RYDÉN L ET AL. Effect on mortality of metroprolol in acute myocardial infarction, a double blind randomized trial. Lancet 1981; 2: 823-32.
20. YUSUF S. The use of beta-blockers in the acute phase of myocardial infarction. In Califf RM and Wagner RS: Acute Coronary Care 1986, Boston, Martinus Nijhoff, 1985; 73-88.
21. ISIS-1 (First International Study of Infarct Survival) Collaborative group: Mechanisms for the early mortality reduction produced by atenolol among 16.027 cases of suspected myocardial infarction. A Randomized trial. Lancet 1986; 2: 57-62.
22. PFEFFER MA, BRAUNWALD E, MOYÉ LA, BASTA L, BROWN EJ JR, CUDDY TE, DAVIS BR ET AL. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival Ventricular Enlargement Trial. N Engl J Med 1992; 327: 669-77.
23. HJALMARSON A, HERLITZ J, MÁLEK I, RYDÉN L, VEDÍN A, WALDENSTRÖM A, WEDEL H ET AL. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1999; 821-8.
24. ISIS-4 A randomized factorial trial assessing early oral captopril, oral mononitrate and intravenous magnesium sulphate in 58.050 patients with suspected acute myocardial infarction. Lancet 1995; 345 (Abstract).
25. THIEMANN D, CORESH J, STEVEN P, GERSTENBLITH G, OETGEN W, POWE N. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation 2000; 101: 2239-46.
26. WHITE H. Thrombolytic therapy in the elderly. Lancet 2000; 356: 2028-30.